FutureGen

China
Genhe, Inner Mongolia, China
+ 86-10-60709130 ★

Company profile

FutureGen company profile

FutureGen is a biopharmaceutical company that develops innovative biologics. The company works in the fields of immunology and cancer, concentrating on the creation and commercialization of novel biologics. The STEP (Structure-based Targeted Evolution Platform) from FutureGen is a cutting-edge screening platform designed specifically for protein drug screening. It integrates several technologies to quickly screen and produce the best antibodies. FutureGen has experience in medication development, clinical research, CMC, and quality in the business world.

Business identity

Contact email
[email protected]
Phone number
+ 86-10-60709130
Operating status
Active
Company type
For Profit
Employee range
00051-00100 employees
Founded
2014-01-01

Headquarters

Headquarters
Genhe, Inner Mongolia, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$46.1M
Last funding
Series B / $46.1M / 2021-03-12
Last equity funding
Series B / $46.1M
Investors
5
Lead investors
1
Founders
1

Founders and investors

Founders

Jin Zhaoyu

Lead investors

Zhongjin Qide

Investors

Dyee CapitalLilly Asia VenturesMSA CapitalSinopharm CapitalZhongjin Qide

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.